Dataset Information

Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

ABSTRACT: To identify proteinases and growth factors abnormally expressed in human corneas of donors with diabetic retinopathy (DR), additional to previously described matrix metalloproteinase (MMP)-10 and -3 and insulin-like growth factor (IGF)-I.RNA was isolated from 35 normal, diabetic, and DR autopsy human corneas ex vivo or after organ culture. Amplified cRNA was analyzed using 22,000-gene microarrays (Agilent Technologies, Palo Alto, CA). Gene expression in each diabetic corneal cRNA was assessed against pooled cRNA from 7 to 9 normal corneas. Select differentially expressed genes were validated by quantitative real-time RT-PCR (QPCR) and immunohistochemistry. Organ cultures were treated with a cathepsin inhibitor, cystatin C, or MMP-10.More than 100 genes were upregulated and 2200 were downregulated in DR corneas. Expression of cathepsin F and hepatocyte growth factor (HGF) genes was increased in ex vivo and organ-cultured DR corneas compared with normal corneas. HGF receptor c-met, fibroblast growth factor (FGF)-3, its receptor FGFR3, tissue inhibitor of metalloproteinase (TIMP)-4, laminin alpha4 chain, and thymosin beta(4) genes were downregulated. The data were corroborated by QPCR and immunohistochemistry analyses; main changes of these components occurred in corneal epithelium. In organ-cultured DR corneas, cystatin C increased laminin-10 and integrin alpha(3)beta(1), whereas in normal corneas MMP-10 decreased laminin-10 and integrin alpha(3)beta(1) expression.Elevated cathepsin F and the ability of its inhibitor to produce a more normal phenotype in diabetic corneas suggest increased proteolysis in these corneas. Proteinase changes may result from abnormalities of growth factors, such as HGF and FGF-3, in DR corneas. Specific modulation of proteinases and growth factors could reduce diabetic corneal epitheliopathy.

SUBMITTER: Saghizadeh M

PROVIDER: S-EPMC1459105 | biostudies-literature | 2005 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Saghizadeh Mehrnoosh M Kramerov Andrei A AA Tajbakhsh Jian J Aoki Annette M AM Wang Charles C Chai Ning-Ning NN Ljubimova Julia Y JY Sasaki Takako T Sosne Gabriel G Carlson Marc R J MR Nelson Stanley F SF Ljubimov Alexander V AV

Investigative ophthalmology & visual science 20051001 10

<h4>Purpose</h4>To identify proteinases and growth factors abnormally expressed in human corneas of donors with diabetic retinopathy (DR), additional to previously described matrix metalloproteinase (MMP)-10 and -3 and insulin-like growth factor (IGF)-I.<h4>Methods</h4>RNA was isolated from 35 normal, diabetic, and DR autopsy human corneas ex vivo or after organ culture. Amplified cRNA was analyzed using 22,000-gene microarrays (Agilent Technologies, Palo Alto, CA). Gene expression in each diabe ...[more]

PMID: 16186340

Similar Datasets

Project description:ObjectiveTo investigate the entire human corneal nerve architecture of donors with different durations of insulin-dependent diabetes mellitus (IDDM).DesignExperimental study.Participants and controlsSixteen fresh human eyes from 8 diabetic donors (aged 43-66 years, with IDDM for 2-17 years) and 12 eyes from 6 normal donors (aged from 44-67 years) were obtained from the National Disease Research Interchange (NDRI).MethodsAfter fixation, corneas were stained with mouse monoclonal anti-?-Tubulin III antibody, and images were acquired to build a whole view of the corneal nerve architecture. The same corneas were used for both whole-mount and cross-section examination.Main outcome measuresCorneal epithelial nerve density was calculated on the basis of the whole-mount view of the central area. The number of stromal nerves was calculated by counting the nerve trunks at the corneoscleral limbus of the entire cornea. Differences between diabetic and normal corneas in epithelial nerve densities and main stromal nerve numbers were compared by paired-samples t test.ResultsThe diabetic eyes presented numerous neuropathies in areas where the epithelial nerve bundles emerged. A striking pathologic change was the presence of abundant nerve fiber loops in the stroma. These loops seemed to form by resistance presented by the basement membrane, which may prevent penetration of stromal nerve branches into epithelia. There was no difference in the numbers of main stromal nerve trunks between corneas from diabetic and normal donors, but there was a significant decrease in central epithelial nerve density in the diabetic corneas. We did not find an age effect on this decrease. Instead, it was significantly affected by 5 or more years of IDDM.ConclusionsThis is the first study to show an entire view of the nerve architecture in human diabetic corneas. The decreased epithelial nerve density may result from the abnormalities of stromal nerve architecture and is affected by 5 or more years of IDDM. Although compensation for some nerve regeneration takes place, the alterations in the stromal nerves can explain the poor healing and persistent epithelial defects seen in diabetic patients.

Project description:Purpose. Diabetic corneas display altered basement membrane and integrin markers, increased expression of proteinases, decreased hepatocyte growth factor (HGF) receptor, c-met proto-oncogene, and impaired wound healing. Recombinant adenovirus (rAV)-driven c-met overexpression in human organ-cultured corneas was tested for correction of diabetic abnormalities. Methods. Forty-six human corneas obtained postmortem from 23 donors with long-term diabetes (5 with diabetic retinopathy) were organ cultured and transduced with rAV-expressing c-met gene (rAV-cmet) under the cytomegalovirus promoter at approximately 10(8) plaque-forming units per cornea for 48 hours. Each control fellow cornea received control rAV (rAV expressing the beta-galactosidase gene or vector alone). After an additional 4 to 5 days of incubation, 5-mm epithelial wounds were created with n-heptanol, and healing was monitored. The corneas were analyzed afterward by immunohistochemistry and Western blot analysis. Signaling molecule expression and role was examined by immunostaining, phosphokinase antibody arrays, Western blot analysis, and inhibitor analysis. Results. rAV-cmet transduction led to increased epithelial staining for c-met (total, extracellular, and phosphorylated) and normalization of the patterns of select diabetic markers compared with rAV-vector-transduced control fellow corneas. Epithelial wound healing time in c-met-transduced diabetic corneas decreased twofold compared with rAV-vector-transduced corneas and became similar to normal. c-Met action apparently involved increased activation of p38 mitogen-activated protein kinase. c-Met transduction did not change tight junction protein patterns, suggesting unaltered epithelial barrier function. Conclusions. rAV-driven c-met transduction into diabetic corneas appears to restore HGF signaling, normalize diabetic marker patterns, and accelerate wound healing. c-Met gene therapy could be useful for correcting human diabetic corneal abnormalities.

Dataset Information

Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Publications

Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure